Are you surprised to learn that the scientific evidence supporting medical cannabis is, in many cases, surprisingly thin? A comprehensive review, spearheaded by UCLA Health, has revealed a significant disconnect between the widespread use of medical cannabis and the actual scientific backing for its effectiveness in treating various conditions.
This in-depth analysis, published in the JAMA journal (you can find it here: ), examined over 2,500 articles published between January 2010 and September 2025. The researchers prioritized over 120 studies, focusing on those with large sample sizes, recent data, and relevance. This research arrives at a time when medical cannabis, including cannabinoids like CBD, has seen a surge in popularity. In fact, a 2018 survey indicated that around 27% of people in the U.S. and Canada have used it for various purposes, such as pain relief, anxiety, and sleep problems.
Dr. Michael Hsu from UCLA Health, the review's lead author, points out a crucial gap between what the public believes and what the latest scientific evidence actually shows.
"While many seek relief from cannabis, our review highlights significant gaps between public perception and scientific evidence regarding its effectiveness for most medical conditions," Dr. Hsu stated. "Clear guidance from clinicians is essential to support safe, evidence-based decision-making when discussing medical cannabis with their patients."
The review did confirm that pharmaceutical-grade cannabinoids, approved by the U.S. Food and Drug Administration, have shown effectiveness, but only for a limited number of conditions. These include medications for HIV/AIDS-related appetite loss, chemotherapy-induced nausea and vomiting, and certain severe pediatric seizure disorders like Dravet syndrome and Lennox-Gastaut syndrome.
But here's where it gets controversial... For the majority of other conditions, the evidence is either lacking or inconclusive. For example, even though over half of medical cannabis users report using it for chronic pain, current clinical guidelines actually advise against cannabis-based medicines as a first-line treatment for this condition.
The review also brought to light potential health risks associated with cannabis use. Longitudinal data from adolescents showed that high-potency cannabis might be linked to increased rates of psychotic symptoms (12.4% versus 7.1% for low-potency) and generalized anxiety disorder (19.1% versus 11.6%).
Furthermore, about 29% of medical cannabis users met the criteria for cannabis use disorder. Daily use, especially of inhaled and/or high-potency products, may also be associated with cardiovascular risks, including higher rates of coronary heart disease, heart attack, and stroke compared to non-daily use.
The review emphasizes that clinicians should carefully assess patients for cardiovascular disease and psychotic disorders, evaluate potential drug interactions, and weigh the risks against the benefits before considering THC-containing products for medical purposes.
Dr. Hsu stresses, "Patients deserve honest conversations about what the science does and doesn't tell us about medical cannabis."
And this is the part most people miss... The authors also acknowledged some limitations in their review. It wasn't a systemic review, and they didn't conduct a formal risk of bias assessment of the included studies. Some studies were observational and could be subject to confounding factors. Additionally, recommendations from clinical trials might not apply universally due to variations in study designs, patient characteristics, and the specific cannabis products tested.
"Further research is crucial to better understand the potential benefits and risks of medical cannabis. By supporting more rigorous studies, we can provide clearer guidance and improve clinical care for patients," Dr. Hsu concluded.
The study involved researchers from prestigious institutions, including Harvard, UC San Francisco, Washington University School of Medicine, and New York University.
What are your thoughts? Do you find these findings surprising? Do you think the potential risks outweigh the benefits in certain cases? Share your perspective in the comments below!
